Fda-Approved
Entity.
- Evidence
- 156 documents · 48 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 6 Apr 2026, last seen 7 Oct 2026
- Measured
- 47% of mentions say something specific about it; the rest only name it
- As of
- 8 Oct 2026
Where this comes from
- The Well News · 2026-10-07 · Policymakers Must Take Action to Preserve the Purpose of Medication Compounding and the Integrity of the Medicine Supply Chain (opens the source in a new tab)
- FDA · 2026-10-07 · Online Generic Medicine/www.onlinegenericmedicine.com - 737806 - 09/23/2026 (opens the source in a new tab)
- Frontiers Precision Oncology · 2026-10-07 · From etiology to precision oncology: a systematic review of the causes and evolving treatments of prostate cancer (opens the source in a new tab)
- TIME · 2026-10-07 · Compounding Pharmacies for Weight-Loss Drugs Are Booming. Should You Trust Them? (opens the source in a new tab)
- BioPharma Dive · 2026-10-03 · Lilly, Foghorn part ways; Wave’s FDA-approved plans (opens the source in a new tab)
- FDA · 2026-10-01 · Drug Safety-related Labeling Changes (SrLC) Database Overview: Updates to Safety Information in FDA-Approved Prescription Drug Labeling (opens the source in a new tab)
- AG Daily · 2026-09-23 · Scientists test FDA-approved drug against New World screwworm (opens the source in a new tab)
- PR Newswire · 2026-09-12 · Meant Health Expands Telehealth Access to FDA-Approved GLP-1 Prescriptions, Including Ozempic® (opens the source in a new tab)
- FDA Drug News · 2026-04-17 · [APPROVAL] First FDA-Approved Treatment for Patients with Focal Segmental Glomerulosclerosis—A Rare Kidney Condition (opens the source in a new tab)
- FDA Press Releases · 2026-04-06 · [APPROVAL] FDA Intends to Take Action Against Non-FDA-Approved GLP-1 Drugs (opens the source in a new tab)